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Abstract
The thesis entitled "Design and synthesis of DNA interactive novel pyrrolo[2,1-c][1,4]benzodiazepine antitumour antibiotics and preparation of 4?-arylaminopodophyllotoxin congeners" has been divided into four chapters. Chapter I gives the general introduction about cancer chemotherapy, covalent, non-covalent interactions of drug-DNA, particularly of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumour antibiotics, DNA-topoisomerase-II inhibitors with particular reference to podophyllotoxin and objectives of the present work. In the Chapter II part A consists of the design, synthesis and DNA binding affinity of novel non-cross-linking mixed imine-amine pyrrolo[2,1-c][1,4]benzodiazepine dimers and their antitumour activity against various human tumour cell lines. Part B describes the new synthetic route for mixed imine-amide PBD dimers and their inhibition of restriction endonuclease, molecular modeling studies. Chapter III comprises of the synthesis and DNA binding affinity of pyrrolobenzodiazepine hybrids in which DC-81 linked to chrysene or pyrene with different alkylamide spacer arms to improve the biological activity. Chapter IV describes the development of new synthetic strategy for the synthesis of epipodophyllotoxin/4 ? f1-O-demethylepipodophyllotoxin and 4?-arylaminopodophylloto- xin congeners as DNA topoisomerase-II inhibitors. 
Chapter-I: General introduction 
Cancer is a disease caused by the misfunctioning of normal cells. Since it involves the conversion of any normal cells to a cancerous cell showing tandem replication and cell divisions at much faster rate in comparison to the normal cells and thus providing a potential target area for the development of chemotherapeutic agents. The major categories of chemotherapeutic agents are antitumour antibiotics, topoisomerase I and II inhibitors, DNA interactive agents and other miscellaneous compounds. Pyrrolo [2,1-c][1,4]benzodiazepines have potential as regulators of gene expression with possible therapeutic application in the treatment of genetic disorders, including cancer, as selective anti-infective agents and as probes and tools for use in molecular biology. The pyrrolo[2,1-c][1,4]benzodiazepine (PBD) class of antitumour antibiotics are derived from various Streptomyces species. These compounds exert their biological activity by covalently binding to the N2 of guanine in the minor groove of DNA through the imine or imine equivalent functionality at N10-C11 of PBD. This aminal linkage thus interferes with DNA function. The molecules have a right handed twist which allow them to fallow on curvature of the minor groove of B-form double stranded DNA spanning three base pairs. 
Topoisomerases are important biological enzymes, which are responsible for the proper topological state and inter conversion of different topological forms of DNA. The DNA topoisomerase enzymes are useful in the area of chemotherapy. DNA topoisomerase II enzyme is a target for a number of clinically useful and experimental antineoplastic agents such as etoposide and teniposide that are semi synthetic analogues of podophyllotoxin. 
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Figure-2 Topoisomerases are important biological enzymes, which are responsible for the proper topological state and inter conversion of different topological forms of DNA. The DNA topoisomerase enzymes are useful in the area of chemotherapy. DNA topoisomerase II enzyme is a target for a number of clinically useful and experimental antineoplastic agents such as etoposide and teniposide that are semi synthetic analogues of podophyllotoxin. 
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